Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.6450
+0.0450 (7.50%)
Aug 12, 2025, 2:44 PM EDT
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 27 employees as of December 31, 2024. The number of employees decreased by 2 or -6.90% compared to the previous year.
Employees
27
Change (1Y)
-2
Growth (1Y)
-6.90%
Revenue / Employee
n/a
Profits / Employee
-$382,276
Market Cap
6.63M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27 | -2 | -6.90% |
| Dec 31, 2023 | 29 | -14 | -32.56% |
| Dec 31, 2022 | 43 | 0 | - |
| Dec 31, 2021 | 43 | 3 | 7.50% |
| Dec 31, 2020 | 40 | 8 | 25.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Silence Therapeutics | 116 |
Brainstorm Cell Therapeutics News
- 4 days ago - BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update - PRNewsWire
- 25 days ago - Brainstorm Cell Therapeutics Crashes 42% After Voluntary Nasdaq Delisting Announcement - Benzinga
- 26 days ago - BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB - PRNewsWire
- 5 weeks ago - FDA Review of Citizen Petition Offers a Fresh Look at NurOwn®'s Evidence of Treatment Effectiveness - PRNewsWire
- 2 months ago - BrainStorm Announces New Survival Data from Expanded Access Program Cohort: Remarkably 90% of ALS Patients Survived Over 5 Years with NurOwn® - PRNewsWire
- 2 months ago - BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn® Phase 3b ALS Clinical Trials - PRNewsWire
- 3 months ago - Brainstorm Cell Therapeutics Inc. (BCLI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn® for ALS - PRNewsWire